knowledge -WSS

knowledge

author：leisure time 2025-09-06 04:41:46 - browse：618

Doctor sitting at a crowded desk. -- first opinion coverage from STAT — Adobe

SAN FRANCISCO — If you learned anything about nonprofit hospitals on the first day of the J.P. Morgan Healthcare Conference, it’s that they’ve all but abandoned the prospect of making significant profit on patient care. Instead, they’re fully throwing their weight into other ways of making money — things like developing drugs or selling insurance.

Making money outside of patient care — or “revenue diversification,” if you prefer industry jargon — has always made appearances on hospital slides at the annual investor conference in San Francisco. This year, though, hospital executives are projecting a sense of urgency around growing profit in other areas to make up for losing money on their bread and butter: taking care of patients in hospitals.

“It used to be nice to have, but now it’s a must-have, especially for not-for-profit health systems,” Niyum Gandhi, the chief financial officer of Boston’s Mass General Brigham said in an interview with STAT after his presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： First U.S. drug developed to treat liver disease MASH is approved

WSS

House looks to weaken Medicare negotiation

Change Healthcare outage fallout shows need for new oversight

Why depression after traumatic brain injury is distinct

Change Healthcare cyberattack outage could last weeks

UCLA team creates talking throat patch for voice disorders

Obesity now affects over 1 billion people worldwide, study finds

knowledge

knowledge

knowledge

How to save PrEP access — and even expand it

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Dobbs anniversary: the lost opportunity of abortion as health care

International team creates first chimeric human

United colonoscopy coverage change 'may cost lives,' doctors say

Why getting cancer drugs just got harder for rural patients

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout Newsletter: CAR

explore

Medical device lobby: We're tired of waiting on Medicare coverage

An inside look at PIPEs, biotech's buzzy new financing tool

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

EPA limits use of carcinogenic gas for sterilizing medical devices

Congress gives doctors Medicare pay bump

How to address the problem of discarded donor organs

hotspot

hotspot

hotspot

focus